Diadema Partners »

Avita Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $128k 25k 5.11

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Avita Therapeutics

Vanguard Group
BlackRock
State Street Corporation
Geode Capital Management
Morgan Stanley
Northern Trust
Millennium Management
AQR Capital Management
Bridgeway Capital Management
Goldman Sachs Group
Divisadero Street Capital Management
Hrt Financial
Jane Street
UBS Group
National Bank Of Canada /fi/

View all funds holding Avita Therapeutics